Literature DB >> 16896053

High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study.

E L Brown1, A Wald, J P Hughes, R A Morrow, E Krantz, K Mayer, S Buchbinder, B Koblin, C Celum.   

Abstract

The relation between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus (HIV) acquisition was evaluated among 4,295 high-risk, HIV-negative men who have sex with men in an intensive behavioral intervention (colloquially referred to as "EXPLORE") study in the United States from 1999 to 2003. Sexual behavior data were obtained by computer-assisted self-interview, and sera were collected semiannually for HIV and HSV-2 serology. HSV-2 infection was classified as "recent incident" (at the first HSV-2 seropositive visit), "remote incident" (within 24 months of the first positive visit), and "prevalent" (for visits >24 months after the first HSV-2 positive visit). Baseline HSV-2 prevalence was 20.3%. HSV-2 incidence was 1.9 (95% confidence interval (CI): 1.6, 2.2) per 100 person-years; significant risk factors were African-American race, unprotected receptive anal intercourse, an HIV-positive male sex partner, and six or more male partners in the prior 6 months. The behavioral intervention did not reduce HSV-2 acquisition (adjusted hazard ratio (HR) = 1.2, 95% CI: 0.9, 1.6). Overall HIV incidence was 1.9 (95% CI: 1.7, 2.2) per 100 person-years. HIV risk was elevated among men who have sex with men with recent incident HSV-2 (adjusted HR = 3.6, 95% CI: 1.7, 7.8), remote incident HSV-2 (adjusted HR = 1.7, 95% CI: 0.8, 3.3), and prevalent HSV-2 (adjusted HR = 1.5, 95% CI: 1.1, 2.1) infection compared with HSV-2 seronegative participants. HIV intervention strategies targeting HSV-2 prevention and suppression among men who have sex with men should be evaluated.

Entities:  

Mesh:

Year:  2006        PMID: 16896053     DOI: 10.1093/aje/kwj270

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

1.  Male circumcision and risk of HIV acquisition among MSM.

Authors:  Jorge Sánchez; Victor G Sal Y Rosas; James P Hughes; Jared M Baeten; Jonathan Fuchs; Susan P Buchbinder; Beryl A Koblin; Martín Casapia; Abner Ortiz; Connie Celum
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

Review 2.  Successes and challenges of HIV prevention in men who have sex with men.

Authors:  Patrick S Sullivan; Alex Carballo-Diéguez; Thomas Coates; Steven M Goodreau; Ian McGowan; Eduard J Sanders; Adrian Smith; Prabuddhagopal Goswami; Jorge Sanchez
Journal:  Lancet       Date:  2012-07-20       Impact factor: 79.321

3.  Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States.

Authors:  Pragna Patel; Tim Bush; Kenneth H Mayer; Sheila Desai; Keith Henry; Edgar Turner Overton; Lois Conley; John Hammer; John T Brooks
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

4.  Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study).

Authors:  Ruanne V Barnabas; Judith N Wasserheit; Yunda Huang; Holly Janes; Rhoda Morrow; Jonathan Fuchs; Karen E Mark; Martin Casapia; Devan V Mehrotra; Susan P Buchbinder; Lawrence Corey
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

5.  A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.

Authors:  Elizabeth E Brittle; Fushan Wang; John M Lubinski; Ralph M Bunte; Harvey M Friedman
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

6.  High HIV-1 incidence, correlates of HIV-1 acquisition, and high viral loads following seroconversion among MSM.

Authors:  Eduard J Sanders; Haile S Okuku; Adrian D Smith; Mary Mwangome; Elizabeth Wahome; Gregory Fegan; Norbert Peshu; Elisabeth M van der Elst; Matthew A Price; R Scott McClelland; Susan M Graham
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

Review 7.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Prediction of HIV acquisition among men who have sex with men.

Authors:  Timothy W Menza; James P Hughes; Connie L Celum; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2009-09       Impact factor: 2.830

9.  Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Authors:  Connie Celum; Anna Wald; James Hughes; Jorge Sanchez; Stewart Reid; Sinead Delany-Moretlwe; Frances Cowan; Martin Casapia; Abner Ortiz; Jonathan Fuchs; Susan Buchbinder; Beryl Koblin; Sheryl Zwerski; Scott Rose; Jing Wang; Lawrence Corey
Journal:  Lancet       Date:  2008-06-21       Impact factor: 79.321

10.  Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study.

Authors:  Junia Rodrigues; Beatriz Grinsztejn; Francisco I Bastos; Luciane Velasque; Paula M Luz; Claudia T V de Souza; Ingebourg Georg; Jose H Pilotto; Valdilea G Veloso
Journal:  BMC Infect Dis       Date:  2009-04-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.